Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $9.24 in the last session, down -4.55% from day before closing price of $9.68. In other words, the price has decreased by -$4.55 from its previous closing price. On the day, 3.61 million shares were traded. MRVI stock price reached its highest trading level at $9.9 during the session, while it also had its lowest trading level at $9.07.
Ratios:
We take a closer look at MRVI’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.28 and its Current Ratio is at 10.00. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on August 13, 2024, Downgraded its rating to Equal-Weight and sets its target price to $10 from $11 previously.
On April 10, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $15.
BofA Securities Upgraded its Neutral to Buy on December 12, 2023, whereas the target price for the stock was revised from $10 to $8.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 28 ’24 when GTCR INVESTMENT XI LLC sold 9,940,974 shares for $9.81 per share. The transaction valued at 97,570,660 led to the insider holds 20,150,005 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 2441660672 and an Enterprise Value of 1682892800. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.41 while its Price-to-Book (P/B) ratio in mrq is 2.99. Its current Enterprise Value per Revenue stands at 6.041 whereas that against EBITDA is 814.172.
Stock Price History:
Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.52. The 50-Day Moving Average of the stock is 12.56%, while the 200-Day Moving Average is calculated to be 24.16%.
Shares Statistics:
According to the various share statistics, MRVI traded on average about 2.39M shares per day over the past 3-months and 4622870 shares per day over the past 10 days. A total of 132.23M shares are outstanding, with a floating share count of 108.70M. Insiders hold about 18.16% of the company’s shares, while institutions hold 95.98% stake in the company. Shares short for MRVI as of 1722384000 were 7920248 with a Short Ratio of 3.31, compared to 1719532800 on 6881478. Therefore, it implies a Short% of Shares Outstanding of 7920248 and a Short% of Float of 6.68.
